The Journal of Heart and Lung Transplantation
Volume 26, Issue 7 , Pages 750-752, July 2007

Alemtuzumab (Campath 1H) as Successful Salvage Therapy for Recurrent Steroid-resistant Heart Transplant Rejection

  • Kenneth J. Woodside, MD
    • ,
  • Scott D. Lick, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Scott D. Lick, MD, Division of Cardiothoracic Surgery, Department of Surgery, University of Texas Medical Branch, 6.120 John Sealy Annex 0528, 301 University Boulevard, Galveston, TX 77555-0528. Telephone: 409-772-1203. Fax: 409-772-1421.

Division of Cardiothoracic Surgery, Department of Surgery, University of Texas Medical Branch, Galveston, Texas.

Received 5 January 2007; received in revised form 16 March 2007; accepted 13 April 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1053-2498(07)00362-2

doi:10.1016/j.healun.2007.04.012

The Journal of Heart and Lung Transplantation
Volume 26, Issue 7 , Pages 750-752, July 2007

Article Tools

* Image Usage & Resolution